« previous next »
Pages: 1 [2]

Author Topic: Rituxan (rituximab)  (Read 491 times)

0 Members and 0 Guests are viewing this topic.

Offline agate

  • Administrator
  • *****
  • Posts: 9478
  • MS diagnosed 1980
  • Location: Pacific Northwest
(Cochrane review) Rituximab for people with MS
« Reply #15 on: November 09, 2021, 02:52:50 pm »
Abstract of a Cochrane review of rituximab for MS in PubMed (November 9, 2021)--"Rituximab for people with multiple sclerosis":


https://pubmed.ncbi.nlm.nih.gov/34748215/
Report to moderator   Logged
MS Speaks--online for 16 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) since 12/16/20.

Offline agate

  • Administrator
  • *****
  • Posts: 9478
  • MS diagnosed 1980
  • Location: Pacific Northwest
(Abst.) Safety and efficacy of Rituxan vs. Tecfidera in patients w/RRMS or CIS...
« Reply #16 on: July 20, 2022, 03:16:52 pm »
From The Lancet (August 1, 2022)--"Safety and efficacy of rituximab versus dimethyl fumarate in patients with relapsing-remitting multiple sclerosis or clinically isolated syndrome in Sweden: a rater-blinded, phase 3, randomised controlled trial":



https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(22)00209-5/fulltext?rss=yes
Report to moderator   Logged
MS Speaks--online for 16 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) since 12/16/20.

Offline agate

  • Administrator
  • *****
  • Posts: 9478
  • MS diagnosed 1980
  • Location: Pacific Northwest
(MedPage Today) Off-label drug lowers relapses in MS
« Reply #17 on: July 21, 2022, 08:42:25 pm »
The study (see previous post) is discussed in an article in MedPage Today (July 21, 2022)--"Off-Label Drug Lowers Relapses in Multiple Sclerosis":


https://www.medpagetoday.com/neurology/multiplesclerosis/99838
Report to moderator   Logged
MS Speaks--online for 16 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) since 12/16/20.

Offline agate

  • Administrator
  • *****
  • Posts: 9478
  • MS diagnosed 1980
  • Location: Pacific Northwest
Some specialists make the case for rituximab to treat relapsing MS
« Reply #18 on: December 16, 2022, 09:46:08 pm »
From Neurology Today (December 15, 2022)--"Should Rituximab Be Considered for Relapsing Forms of MS?  Some Specialists Make the Case for It":


https://bit.ly/3jbEue3


Neurology Today is a publication of the American Academy of Neurology.
Report to moderator   Logged
MS Speaks--online for 16 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) since 12/16/20.

Offline agate

  • Administrator
  • *****
  • Posts: 9478
  • MS diagnosed 1980
  • Location: Pacific Northwest
(Abst.) Predictors of hospitalization due to infection in rituximab-treated MS patients
« Reply #19 on: February 27, 2023, 09:36:28 pm »
From PubMed, a study done in Norway is reported on (February 27, 2023)--"Predictors of hospitalization due to infection in rituximab-treated multiple sclerosis patients":


https://pubmed.ncbi.nlm.nih.gov/36842313/
Report to moderator   Logged
MS Speaks--online for 16 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) since 12/16/20.
Pages: 1 [2]
« previous next »
 

Related Topics

  Subject / Started by Replies Last post
1 Replies
187 Views 		Last post June 14, 2017, 10:35:24 am
by agate
0 Replies
84 Views 		Last post May 30, 2018, 12:19:55 pm
by agate
0 Replies
81 Views 		Last post September 29, 2018, 11:36:07 am
by agate
0 Replies
65 Views 		Last post October 05, 2019, 07:51:03 am
by agate
0 Replies
35 Views 		Last post February 10, 2021, 09:39:05 pm
by agate